Clinical Trials Logo

Refractive Errors clinical trials

View clinical trials related to Refractive Errors.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06462456 Not yet recruiting - Refractive Errors Clinical Trials

Post-market Clinical Follow-up Study of Alcon PRECISION1™ Spherical and PRECISION1™ for Astigmatism Soft Contact Lenses

Start date: August 2024
Phase:
Study type: Observational

The purpose of this study is to assess long term performance and safety of verofilcon A soft contact lenses in a real-world setting in a population of 7 years or older having at least 1 year of verofilcon A (sphere or toric) contact lens wear in a daily wear and daily disposable modality.

NCT ID: NCT06408649 Not yet recruiting - Myopia Clinical Trials

Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)

Start date: August 2024
Phase:
Study type: Observational

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to continuously assess the visual performance and safety of TOTAL30 Sphere and TOTAL30 for Astigmatism contact lenses in a real-world setting across a broad variety of patients through routine clinical practices.

NCT ID: NCT06379477 Not yet recruiting - Refractive Errors Clinical Trials

Correction of Refractive Error Surprises After Cataract Surgery in Adults

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

A refractive surprise can be defined as the failure to achieve the intended postoperative refractive target or the presentation of unexpected and, unwanted post-operative refractive error. It can cause anisometropia or dominance switch and is a source of patient dissatisfaction due to unmet expectations.The best way to manage refractive surprise is to prevent it. The 2017 NICE guidelines on the management of cataracts provide advice on prevention of refractive surprise through accurate biometry, A-constant optimisation, intraocular lens (IOL) formula selection and avoiding wrong lens implant errors.Benchmark standards for NHS cataract surgery dictate that 85% of eyes should be within 1 dioptre (D) and 55% within 0.5D of target spherical equivalent refraction following surgery.

NCT ID: NCT06295536 Not yet recruiting - Ametropia Clinical Trials

Optimization of a Photoretinoscopy Method for Determining the Objective Refraction of Children

Start date: March 2024
Phase: N/A
Study type: Interventional

The objective is to compare the refractive parameters of the photorefraction prototype device without cycloplegia with the refractive parameters of reference device, an autorefractometer with and without cycloplegia.

NCT ID: NCT06166212 Not yet recruiting - Refractive Errors Clinical Trials

Changes in Angle Kappa and Corneal Back Elevations After Laser in Situ Keratomileusis in Myopic Astigmatism

Start date: January 2024
Phase:
Study type: Observational

Refractive errors and corneal astigmatism are associated with changes in angle kappa and corneal back elevation at the thinnest point in Pentacam. The purpose of this study is to track: The effect of anterior corneal astigmatism treatment on angle kappa and corneal back elevation.

NCT ID: NCT06044688 Not yet recruiting - Astigmatism Clinical Trials

EyeQue VisionCheck 510(k) Clinical Trial

Start date: October 2023
Phase: N/A
Study type: Interventional

Demonstrate that refraction measurements from the device agree with refraction measurements from a phoropter within clinically meaningful limits.

NCT ID: NCT05964634 Not yet recruiting - Myopia Clinical Trials

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia

Start date: August 1, 2023
Phase:
Study type: Observational

This study intends to analyze the characteristics between peripapillary retinal nerve fiber layer thickness and peripapillary area in high myopia with or without glaucoma

NCT ID: NCT05781997 Not yet recruiting - Refractive Errors Clinical Trials

Prevalence of Refractive Errors in Primary School Children

Start date: May 1, 2023
Phase:
Study type: Observational

The study aim to determine the prevalence of refractive errors in primary school children aged 6-12 in The New Valley , Egypt .

NCT ID: NCT05741190 Not yet recruiting - Clinical trials for Aberration, Corneal Wavefront

Correlation of Angle Kappa , Corneal High Order Aberrations and Total Eye Aberrations in Various Refractive Errors

Start date: May 1, 2023
Phase:
Study type: Observational

Identification of the correlation between angle kappa , corneal high order aberrations and total eye aberrations in myopic hyperopic and astigmatic patients

NCT ID: NCT05588362 Not yet recruiting - Myopia Clinical Trials

Access to EyeGlasses for School-aged Children

ATEG
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Uncorrected refractive error is a leading cause of visual impairment in children and can impact vision, quality of life, and academic performance. Despite Boston Children's Hospital serving patients from a wide range of socioeconomic backgrounds, there are health disparities in access to eyeglasses as a consequence of patients' health insurance. The investigators will examine whether the use of an in-clinic app for 3-D printed glasses reduces disparities in access to eyeglasses for our patients on Medicaid. The intervention will address social determinants of health and improve pediatric health outcomes namely, how and when children having publicly funded health insurance receive eyeglasses. The short-term objectives are (1) to compare the time to receive glasses between publicly funded MassHealth eyeglasses and an in-clinic order of 3D printed glasses (2) to evaluate compliance with glasses wear in these two groups, and (3) to evaluate visual function and quality-of-life outcomes in these two groups. This prospective randomized control study will evaluate barriers to accessing eyeglasses in school-aged children. The investigators will recruit children enrolled in MassHealth and randomize them into two cohorts: (1) the control group will receive MassHealth glasses as per standard of care, through an optical shop of their choosing, or (2) the intervention group will use an app for immediately ordering glasses (paid for by the study) in clinic following their appointment. The investigators will evaluate the time needed to receive eyeglasses, compliance with glasses wear, quality of life, and visual outcomes between the cohorts at one-, three-, and six-month intervals. Through this project, the investigators will not only evaluate, quantify, and bring awareness to disparities in our patient population, but will also look toward finding a solution through the use of a novel application that addresses many of the barriers faced by patients insured through Medicaid.